Objective. The aim of this study was to evaluate the effects of acupuncture treatment on serum levels of serotonin and substance P (SP) as well as on clinical parameters in patients with fibromyalgia (FM).
Introduction
Fibromyalgia (FM) is a kind of nonarticular soft tissue rheumatism characterized by chronic and widespread musculoskeletal pain, short-term stiffness, subjective swelling feeling, fatique, and sleep disturbances [1] . Prevalence of FM is about 2-4% of the general population, and 80-90% of patients are women [2] . Although FM is the second most common painful disorder, the etiopathogenesis is certainly unclear. At the beginning, microtraumas, local inflammations, and aberrant microcirculation on muscles were blamed for mechanisms of FM [3] . Nowadays, however, etiopathogenesis focuses on changing pain mechanisms and stress management. Several hypotheses are suggested regarding FM, including altered hypothalamus-pituitary-adrenal (HPA) axis, changing peripheral nociception, and central sensitization [4] .
One major hypothesis in the etiology of FM is serotonergic dysfunction. Serotonin has an important role in pain, emotion, mood, cognition, and various motor functions [5] . Several reports determined low serotonin values in patients with FM [6, 7] . Also, a strong correlation was observed between lower levels of serotonin and pain or hyperalgesia [8] . The implication was that low levels of serotonin may be related to other abnormal factors, such as altered HPA axis and sympathetic hyperactivity in FM [9] . Another important mediator in pain transmission and sensation is substance P (SP). It works in nociception, hyperalgesia, allodynia, and neurogenic inflammation [10, 11] . It was reported that SP levels increase in the cerebrospinal fluid (CSF) of FM patients [12] . Also, serotonin and SP abnormalities may influence pain thresholds in FM.
As FM is a chronic painful disease and the etiopathogenesis remains unclear, there is no gold standard treatment for FM patients. Several pharmacologic and nonpharmacologic approaches, such as exercise, cognitive behavior therapies, and patient education are recommended in FM treatment [13, 14] . The pharmacological treatments include mainly antidepressants, analgesics, and muscle relaxants. However, limited benefit, insufficient response to symptoms other than pain, and side effects due to pharmacological drugs restrict its use [15] . Patients who suffer from chronic FM seek alternative therapy because of conventional medicine failure [16] . It was reported that more than 90% of FM sufferers experienced at least one kind of CAM [17] .
The American Pain Society FM guidelines report moderate evidence for acupuncture therapy in the treatment of FM according to clinical trials [18] . Also, the NIH accepted as a consensus statement that acupuncture therapy may be a useful adjunct or alternative treatment for FM [19] .
Many studies have shown the benefits of acupuncture in the symptoms of FM [15, 16] . However, the majority of these reports focused on pain reduction. Patients with FM have not only pain, but other symptoms as well, such as morning stiffness, anxiety, depression, lower quality of life, fatique, and sleep abnormalities. Although important improvements were reported with acupuncture treatment in patients with FM, the effect mechanism of acupuncture is unknown. Acupuncture may regulate to one or more altered etiopathogenetic mechanisms in the treatment of FM.
Acupuncture treatment has both local effects, such as local microinflammation due to needles, an increase in local blood flow, and analgesia, and general effects, such as somato-autonomic reflex and neurotransmitters in the brain [20] . Several studies have shown that the stimulation of acupoints can affect the concentrations of various mediators, such as endorphin, serotonin, SP, and enkephalin in the brain and local tissues [21] [22] [23] . Although it is well known that abnormalities in pain regulation play an important role in FM clinical symptoms, there are few studies investigating the relationship between changes in pain-modulating substances and in clinical symptoms with acupuncture treatment in patients with FM [24] . Also, acupuncture treatment can change SP and serotonin concentrations in several acupoints and in patients with a variety of diseases; however, there are no adequate clinical trials regarding this issue in FM [25] [26] [27] .
If acupuncture is effective in pain reduction of patients with FM, changes in serotonin and SP levels may explain how acupuncture works in the treatment of FM. However, to the best of our knowledge, the effects of acupuncture treatment on serum SP and serotonin levels have not been previously investigated with a randomized controlled clinical trial (RCT) in patients with FM. Therefore, we aimed to investigate if acupuncture therapy can change serum SP and serotonin levels as well as clinical parameters.
Methods
This study was conducted at the Physical Medicine and Rehabilitation Department of Ataturk University. The study was approved by the local ethics committee of Ataturk University. All participants were informed about the study protocol but not about the kinds of groups. Their written informed consents were obtained according to the Declaration of Helsinki.
Seventy-five female patients with FM (age 20-50 years) were enrolled in this study. The number of tender points (NTP) was an important clinical assessment parameter in the study. Therefore, the 1990 American College of Rheumatology (ACR) FM criteria, which included NTP, were used for FM diagnosis instead of the 2010 ACR criteria [28, 29] .
People who had taken nonsteroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, tricyclic antidepressant or any antidepressant drugs in the previous 15 days, and who smoked, who had a bleeding diathesis or painful medical conditions other than FM were not included. Also, patients who had prior experience with any acupuncture therapy were excluded from the study. Randomization was assured through a simple randomization method, using closed envelopes with numbers inside. Seventy-five female patients were randomly assigned to three groups: the acupuncture group (AcG), the sham acupuncture group (ShG), and the simulated acupuncture group (SiG). In the AcG, acupuncture treatment was performed on 18 acupoints designed to treat FM with 0.25Â25 mm stainless steel needles. These standardized acupoints were Du-14 (Da Zhui), Si-15 (Jian Zhong Shu), Li-4 (He Gu), Li-11 (Qu Chi), H-7 (Shen Men), P-6 (Nei Guan), Ren-6 (Qihai), Liv-3 (Tai Chong), St-36 (Zu San Li), and Sp-6 (San Yin Jiao). They were used bilaterally, except Du-14 and Ren-6 points (Figures 1 and 2 ).
Two different control groups were used in this study. The sham control group was enrolled to assess the effect of needle insertion into the skin. The simulated control group was used to define the psychological effects of acupuncture therapy.
In the ShG, 18 needles, the same size as the AcG's needles, were inserted into 18 sham points that are not recognized as acupoints or in meridians. These sham points were defined by using an acupuncture point search dedector approximately 1-2 cm from AcG's acupoints. The points, which have lower signals than acupoints according to the dedector, were used as sham points.
In the SiG, 18 identical real acupoints with the AcG were used. Noninsertive simulated acupuncture was performed on this group. First, a small circular adhesive bandage was applied on an acupoint. Then, a short needle (0.25Â15 mm) was inserted into the bandage but not into the skin. In this group, short needles were preferred, so that patients assumed that the needles had been inserted into the skin. While the needles were inserted into acupoints and sham points, they were not inserted into the points of the SiG. Also, small circular adhesive bandages were used in all groups to ensure the same appearance among patients.
Blinding
The treatments in all three groups were performed by the same licensed acupuncturist, who has seven years' experience. However, clinical assessments of patients were evaluated by another researcher who was unaware of the treatment groups.
In addition, an experimental setup was used to provide eligible blinding of a patient to the kind of treatment In addition, these needles were checked to ensure that they did not touch the table. The curtain with the free lower end was released between the face and body. Therefore, the patient was not able to observe the treatment procedure ( Figure 3 ). After that, the treatment was performed according to the patient's group.
Three kinds of treatments were conducted semiweekly for four weeks, for a total of eight sessions. Each session lasted 30 minutes. Needles were not manipulated.
Assessments and Measurements
Patients were clinically assessed at baseline, after the last treatment, and at one and three months after the completion of all treatments. Clinical outcomes were pain, NTP, clinical assessments, depression, and general health status.
Generalized widespread pain was measured by the visual analog scale (VAS; 0 ¼ no pain, 10 ¼ the most intense pain). The Fibromyalgia Impact Questionnaire (FIQ) was used for FM clinical assessment. This standardized and validated tool has been translated into Turkish and validated [30] . Also, general health status was assessed by Nottingham Health Profile (NHP). NHP is designed to measure health-related quality-of-life dimensions, such as emotional, social, and physical health. It has six dimensions, including pain, energy, physical mobility, emotional reactions, social isolation, and sleep. Each subscale score is used for assessment. The validity and reliability of the Turkish version of NHP has been performed by Kucukdeveci et al. [31] . FM is a chronic disease and may be easily affected by emotional changes. Therefore, depression status was also evaluated by Beck Depression Inventory (BDI). The BDI, including 21 items, was translated into Turkish; it was validated in 1998 [32] .
In addition to clinical assessments, serum serotonin and SP levels were measured. Venous blood samples were obtained at baseline and after the completion of all treatments. Serum samples were stored at -80 C until analyzed. The serum serotonin and SP levels were measured with commercial kits using the enzymeimmunoassay (EIA) method.
Statistical Analysis
Statistical analysis was performed with the SPSS 18.0 packet program for Windows. The repeated-measures analysis of variance (RMANOVA) was used to determine group effects (AcG, ShG, SiG), within-subject effects, and interactions between groups and time. The sphericity assumption was checked with Mauchly's test, and Gerainhause-Geisser P values were used. One-way ANOVA and Tukey honest significant difference post hoc tests were used to determine differences for serotonin and SP levels among groups. Comparisons of data were examined within groups by paired-samples t test. Also, correlations between serum markers and clinical data were evaluated by the Pearson correlation test. Values with P < 0.05 were deemed statistically significant.
Results
Seventy-five female patients with FM were enrolled in the study. However, seventy-two patients completed the study. One subject in each of AcG and SiG dropped out for individual reasons. Also one participant in the SiG was removed from the study because she did not continue to attend treatment sessions ( Figure 4 ). There were no serious adverse effects in any of the three groups. Only some patients experienced discomfort and bruising at the sites of needle insertion, especially in the ShG. However, patients tolerated it well and did not complain about the adverse effects.
When demographic characteristics of the patients were analyzed, the mean ages were found to be 34. mean disease durations of 4.44 6 3.99, 3.94 6 3.30, and 5.09 6 3.39 years, respectively. There were no significant differences in terms of age, BMI, or disease durations for patients among the groups (P > 0.05).
In the AcG, significant improvements were found in NTP, VAS, FIQ, and BDI scores, as well as some subscales of NHP, after treatment (Tables 1 and 2 ). These improvements usually continued by the three-month mark. In the ShG, significant changes were observed in NTP, VAS, FIQ, and BDI scores after treatment. These improvements continued for NTP and FIQ scores for three months. In the SiG, significant improvements were found only in the NTP, VAS, and BDI scores after treatment. They were not observed by the following assessments.
When group and time effects were analyzed by RMANOVA, with respect to time (from baseline to three months), changes in mean VAS, NTP, FIQ scores, BDI scores, and some NHP subscales of the AcG were significantly different from both of the other groups ( Figure 5 , A-D).
Serum serotonin values increased significantly after treatment in the AcG and ShG (P < 0.001 and P < 0.01, respectively) ( Figure 6 ). The increase in the AcG was also different from both of the other groups (P < 0.01). Serum SP levels decreased significantly in the AcG (P ¼ 0.001). However, while the levels increased in the SiG (P ¼ 0.001), they did not change in the ShG after treatment ( Figure 7 ). The increase in the SiG was different from both the AcG and ShG.
In addition, there was no significant relationship between baseline serum markers and the clinical parameters (Table 3) . However, some negative correlations were found between the change in serum markers and the change in other parameters in the ShG (Table 4) .
Discussion
Serotonin is a very important neurotransmitter for sleep, temperature, depression-anxiety, feelings, sexual behavior, and pain regulation [5, 33] . Also, different pharmacologic agents that increase serotonin are used effectively in the treatment of FM. SP is a neuropeptide and is related to pain, depression, nausea-vomiting at the central nervous system, and neurogenic inflammation at the peripheral nervous system [34] . Several medicines that are used in FM treatments, such as pregabalin, cause an analgesic effect via SP [35] .
In addition, some nonpharmacological therapies such as massage therapy and aerobic exercise may also lead to increases in serotonin and to decreases in SP levels in pain reduction in FM [36, 37] . However, the effect mechanism behind acupuncture in FM treatment remains unclear. We found only one clinical study investigating the effects of acupuncture therapy on serotonin and SP levels in FM. However, it was not an RCT. Sprott et al. [24] performed six sessions of individual acupuncture therapy for six weeks in 29 patients with FM. They evaluated pain with VAS and the NTP and assessed serum SP values and serum and platelet serotonin levels. They found significant improvements in pain and the NTP, a decrease of serotonin levels of platelets, Figure 4 Participant flow diagram.
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and an increase in serum SP and serotonin values. However, that study had some limitations. First, it did not include a control group. Therefore, it was very difficult to determine whether the improvements and changes in serotonin and SP values were related to acupuncture efficacy or not. In addition, there were no particular clinical parameters or validated indices regarding FM, except pain and the NTP evaluations.
Our study was a double-blinded RCT. We aimed to investigate whether acupuncture had an effect on symptoms and serum levels of serotonin and SP in the study. We hypothesized that acupuncture efficacy on symptoms and clinical parameters may be associated with changes in the levels of pain-modulating substances, including serotonin and SP, in the treatment of FM. In this study, serotonin levels increased significantly with AcG and ShG. As changes were more prominent in the AcG than in the ShG, the increase of serotonin levels may depend not only on the insertion of the needle, but also on the specific effects of real acupuncture.
Some interesting results were found in this study. First of all, although serotonin is known to be related to emotions, it did not change with noninserted placebo acupuncture in the SiG. The second important result was regarding the levels of SP changes. While SP levels decreased in the AcG, they increased in the SiG. This result seems to depend on real acupuncture effects rather than on the effects of needle insertion or placebos. In addition, increased serotonin values may also have contributed to the reduction of SP levels in the AcG. An inverse relationship between serotonin and SP may occur in FM. Serotonergic neurons play an inhibitory role, especially in spinal pain pathways [6] . An increase of serotonin concentrations with a stimulus in the periphery decreases SP expression in the spinal cord [38] . Therefore, an increase of serotonin levels with acupuncture therapy may have affected the SP levels of our patients. The intermediate increase of serotonin due to the insertion of the needle in the ShG may be insufficient to suppress SP levels.
The relationship between the values of serotonin and SP and the clinical parameters of FM has been investigated in clinical studies. Schwarz et al. [39] found a negative correlation between serum SP and serotonin values in FM. While high concentrations of SP were related to sleep abnormalities, there was no correlation between serotonin levels and clinical parameters. Also, Yunus et al. [8] reported a negative correlation between plasma tryptophan levels and both pain and daily stress. However, Dessein et al. [40] did not find any association between serum serotonin levels and the FIS scale. Also, Wolfe et al. [7] showed an association between serum serotonin values and clinical parameters, such as depression and tender point count. In our study, no correlation was found either between clinical assessments or serum markers. These controversial results may be attributed to the differences in measurement methods of serotonin and SP values, such as high-performance liquid chromatography, enzyme-linked immunosorbent assay, and double antibody radioimmunoassay.
Also, serum serotonin and SP levels were assessed to determine the peripheral effectiveness of acupuncture in this study. Serum serotonin and SP values may not always have a correlation to levels in the CNS. Further well-designed RCTs are needed to investigate the effects of acupuncture on peripheral and central serotonin and SP values in patients with FM.
Some clinical trials in acupuncture have reported beneficial improvements in the treatment of FM. However, the quality of the trials is poor and the risk of bias is high, according to a recent systematic review [41] . There are few RCTs for acupuncture therapy in FM, and controversial results have been reported. Deluze et al. [42] conducted an RCT study of 70 patients with FM including electroacupuncture and sham acupuncture groups. They found significant improvements in the pain threshold, the number of analgesics, pain scores, sleep, and both the patients' and the physicians' global assessments in the electroacupuncture group vs the sham group. However, that study did not use any reliable validated tool for FM. Also, there was no follow-up.
Itoh and Kitakoji [43] conducted a 10-session study of electroacupuncture vs a five-week control period and a five-session study of electroacupuncture for 16 patients. They found significant improvements in pain intensity and quality of life in the pure electroacupuncture group in week 5. However, there were some limitations in that study. The subject size was very small in each group (N ¼ 6 and N ¼ 7). In addition, the acupuncturist performed both electroacupuncture and trigger point needling for each patient. However, trigger point needling is different from Ashi point acupuncture. Trigger points usually occur in myofascial pain syndrome. However, there is not a trigger point in every patient with FM. Local twitch response is observed when the trigger point is needling, but this response does not occur in Ashi point acupuncture. The other issue is that the authors compared 10 acupuncture sessions of one group with five acupuncture sessions of the other group after 10 weeks. As there was no follow-up to the study, it is unknown whether or not the improvements in either group will continue.
Assefi et al. [44] performed a well-designed RCT including 24 acupuncture sessions in FM. They chose three different sham and placebo groups for unrelated conditions, needling on nonacupoint locations, or using noninservative simulated acupuncture. As a result, the effect of real acupuncture on pain did not differ from the three kinds of sham or placebo groups according to that study. However, interventions were applied by eight Figure 5 The changes of the mean visual analog scores (A), the number of tender points (B), the Fibromyalgia Impact Questionnaire scores (C), and the Beck Depression Inventory scores (D) of the three groups depend on time. BDI ¼ Beck Depression Inventory; FIQ ¼ Fibromyalgia Impact Questionnaire; VAS ¼ visual analog score.
different acupuncturists in the study. Some RCTs and meta-analyses reported that communication styles of the acupuncturists and expectation of benefits have important roles in the effectiveness of both sham acupuncture and real acupuncture [45] [46] [47] , so varying attitudes of the eight therapists may affect the results. In our study, all interventions were performed by the same acupuncturist. Also, as mentioned in the article by Assefi, patients continued with their pharmacological and nonpharmacological treatments. Therefore, the benefits of other treatments may have had an unequal effect on the results in each group. Also, the results of this study seem to reflect the effectiveness of adjunctive acupuncture but not of acupuncture treatment in FM.
Martin et al. [48] conducted a well-designed RCT with 50 patients. The acupuncture group received standard manual acupuncture and electroacupuncture for six sessions. They also added some acupoints during the last three sessions. The control group was similar to our simulated group. They used a nonpenetrating model without electrical current as the control group. They used the Multidisciplinary Pain Inventory and FIQ and followed patients for seven months after treatment. It was reported that treatment was primarily beneficial in pain, fatigue, and anxiety subscales, which they observed one month after the treatment. The benefits did not have a significant outcome at the seven-month mark. Also, they used a well-designed experimental setup to achieve blinding of participants. Patients were seated, and a screen and blanket were placed under their jaws, so they did not observe their treatments. It was a very effective method in providing reliable blinding and a realistic placebo treatment. However, it sometimes caused neck pain in patients. In addition, acupuncture treatment in a sitting position may cause more vasovagal symptoms than in the supine position. In our study, another useful and inexpensive setup was used for the blinding of participants in this study. It was the curtain of a hospital screen with three folding sections, so that the patients could not observe their own treatment. In addition, while Martin et al. reported vasovagal symptoms in two patients, patients did not experience vasovagal symptoms in any of our groups. The supine position may prevent such adverse effects and can be more relaxing than a sitting position. Therefore, we recommend this simple setup to achieve reliable blinding of participants in acupuncture clinical trials.
These controversial results of acupuncture studies may be due to various factors: the selection of points, therapy frequency and durations, various follow-up durations, different style control groups such as sham, simulated, and superficial acupuncture, and insufficient blinding. The choice of a suitable placebo group is very important for acupuncture RCTs. Some researchers prefer using sham acupuncture in nonmeridian points or unrelated acupoints in their trials. Others have used superficial needling in real acupuncture points in the control group. However, even superficial needling on Figure 6 Serum serotonin values at baseline and after completion of all treatments in the three groups. While the white background represents levels of baseline, the black background represents levels after the treatments in each group. *P ¼ 0.002: the difference of serum serotonin levels after the treatments between acupuncture and sham acupuncture groups. **P ¼ 0.006: the difference of serum serotonin levels after the treatments between acupuncture and simulated acupuncture groups.
Figure 7
Serum substance P values at the baseline and after completion of all treatments in three groups. While the white background represents levels of the baseline, the black background represents levels after the treatments in each group. *P < 0.001: the difference of serum substance P levels after the treatments between acupuncture and simulated acupuncture groups. **P ¼ 0.041: the difference of serum substance P levels after the treatments between sham acupuncture and simulated acupuncture groups.
acupoints or nonmeridian points may cause some physiological response as some degree of acupuncture [49] . Therefore, sham acupuncture or superficial acupuncture may not be inert intervention [50] . Simulated acupuncture is chosen by acupuncturists in some RCTs as a control as well. It can be performed by nonpenetrating placebo needles, toothpicks, and needling to an adhesive bandage but not the skin. However, even Table 4 The correlations between change in serum markers and change in clinical parameters touching the skin may generate a stimulus and start chemical or physiological reactions [51] . In this study, two control groups were used. The sham control was chosen to determine the effects of inserting the needles. The simulated control was included to observe placebo effects. Although most improvements were found in the AcG, it was determined that there were some effects at various degrees in both the ShG and the SiG.
These improvements in the ShG or SiG may be due to several factors. First, the patients' expectations are very important. Patients with FM may already have strong placebo responses according to studies that included other blinded interventions [52] . Moreover, as FM patients have long-term chronic pain and other clinical symptoms, they have presumably already tried a number of pharmacological treatments. Acupuncture therapy is an encouraging and relatively new treatment option for them. Therefore, even patients in the SiG may feel some improvement in symptoms. These improvements may also affect neuromediators related to mood and pain. Second, there is also physical contact in acupuncture therapy, apart from pharmacologic treatments. This proper touching partly occurs even in the noninserted simulated group when the acupuncturist sticks the flaster on the skin. Such physical contact may turn into a psychological relationship or may generate confidence between a therapist and a patient [53] . This effect has been reported by Nakamura and Yukawa [54] in a clinical study on 197 patients. They found that proper touching and positive attitudes of the therapist were associated with the effectiveness of acupuncture and moxibustion therapy. Researchers concluded that acupuncture and moxibution therapy may also act as a kind of psychotherapy.
Another interesting result of our study was the duration of the effect. The time course of improvement is very important to distinguish the effects of real acupuncture from sham or placebo acupuncture. We determined that patients undergoing sham and placebo acupuncture also showed some improvements. However, the benefits did not continue after the noninservative acupuncture therapy. In this case, the limited effect of the SiG may have depended on placebo effects, such as the patient's expectation of benefits, the relationship between the patient and the therapist, and the effect of touching when the adhesive bandage is applied. As placebo effects were not expected to have long-term benefits, all improvements may diminish at the end of simulated therapy. On the other hand, some treatment benefits lasted at follow-up in both the ShG and the real AcG. These results may be related to the physiological reactions of needle insertion and the specific effects of real acupuncture. The penetration of the skin with needles may also cause some physiological effects in ShG. However, these effects are usually short term. In our ShG, most improvements, except the NTP and BDI scores, did not continue after three months. In addition, ShG reduced pain scores just after the treatment as well as in the SiG, but not at the one month mark.
This effect may also be due to placebo effects rather than needling. On the other hand, the benefits in the AcG continued for three months. Also, improvements in nearly all of the clinical parameters were still significantly different from that of the other two groups at the threemonth mark. This result may show that real acupuncture, as opposed to sham acupuncture or placebo acupuncture, has important and long-term effects. The degree and duration of the influence of acupuncture seem superior to sham and placebo interventions. This result may also be associated with different effect mechanisms of real acupuncture and sham acupuncture despite similar clinical improvements. Also, several functional magnetic resonance imaging studies have shown that sham acupuncture, as opposed to real acupuncture, has led to the activation of the brain pain pathway structures with similar but lower intensity [45] . Harris et al. [55] found that acupuncture has a similar effect on pain reduction as skin-penetrating sham acupuncture by a clinical image study in FM. They reported that while acupuncture and sham acupuncture had similar reductions in clinical pain, they altered differentially to central l-opioid receptor binding potential, which is known to be reduced in FM patients according to positron emission tomography. In addition, we determined different effects of real acupuncture and sham acupuncture on serotonin and SP values.
Our study may have limitations. The relatively small size and exclusively female gender of participants may have affected the results. As the female/male ratio is 9:1 in FM, this study was conducted only with female patients. However, our results may not be similar to male patients with FM. As our study included sham and simulated acupuncture arms, attention was not given to the sensation of deQi. Also, the manipulation of needles or individualized point choice was not used for similar reasons. Therefore, the real effectiveness of acupuncture may be more prominent than our results indicate.
Conclusion
We evaluated the effects of acupuncture on serum SP and serotonin levels as well as clinical parameters in FM with this first RCT. We found important improvements not only in pain but also in the NTP, clinical parameters, depression, and general health status in the AcG. The main difference between the effects of real acupuncture and sham or simulated acupuncture may be in the degree and duration of improvements in the treatment of FM patients. Real acupuncture may produce a stronger response than sham or placebo acupuncture. Also, the effectiveness of acupuncture in FM symptoms may continue for a longer time. Also, real acupuncture may have a different effect on neuromediator values, such as serotonin and SP, which are included in the etiopathogenesis of FM. Changes in serotonin and SP levels may explain why certain beneficial effects exist in acupuncture therapy in FM. Further studies investigating acupuncture effects on other altered substances such as
